LX Holdings will place its 2025 management focus on expanding revenue streams abroad even in the face of mounting ...

Lexicon is eligible to receive upfront and near-term milestone payments of up to $75 million. In total, Lexicon will be eligible to receive $1 billion in upfront and potential development, regulatory ...

Lexicon Pharmaceuticals (LXRX) announced that it has entered into an exclusive license agreement with Novo Nordisk (NVO) for LX9851, a ...

Driver’s Seat: The MDX Type S front row is a super comfortable place to be. The leather feels lived-in, even though the ...